Big Pharma would rather buy back than pay forward By: MarketWatch May 07, 2015 at 13:35 PM EDT Big Pharma is cutting back on basic research while spending more money on share buybacks, writes Jim O’Neill. Read More >> Related Stocks: Apple Merck & Co